PF-04802367 is primarily used in the field of neuroscience research, particularly in the study of neurological disorders. It is known for its role as a potent and selective inhibitor of phosphodiesterase 10A (PDE10A), an enzyme that plays a crucial role in regulating intracellular signaling pathways in the brain. By inhibiting PDE10A, this compound helps researchers investigate the potential therapeutic effects for conditions such as schizophrenia, Huntington's disease, and Parkinson's disease. Its application in preclinical studies aids in understanding the modulation of cyclic nucleotide signaling, which is essential for developing targeted treatments for these disorders. Additionally, it serves as a valuable tool in pharmacological studies to explore the behavioral and biochemical effects of PDE10A inhibition in animal models.